Titre:
  • A randomized, double-blind, placebo-controlled, phase 2b Study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation
Auteur:Vincent, Jean Louis; Ramesh, Mayakonda Krishnamurthy; Ernest, David; LaRosa, Steven; Pachl, Jan; Aikawa, Naoki; Hoste, Eric; Levy, Howard; Hirman, Joe; Levi, Marcel; Daga, Mradul; Kutsogiannis, Demetrios James; Crowther, Mark; Bernard, Gordon; Devriendt, Jacques; Puigserver, Joan Vidal; Blanzaco, Daniel D.U.; Esmon, Charles C.T.; Parrillo, Joseph J.E.; Guzzi, Louis; Henderson, Seton S.J.; Pothirat, Chaicharn; Mehta, Parthiv; Fareed, Jawed; Talwar, Deepak; Tsuruta, Kazuhisa; Osawa, Yutaka; Kaul, Inder; Gorelick, Kenneth K.J.
Informations sur la publication:Critical care medicine, 41, 9, page (2069-2079)
Statut de publication:Publié, 2013-09
Sujet CREF:Soins intensifs réanimation
Mots-clés:coagulopathy
organ dysfunction
sepsis
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0090-3493
info:doi/10.1097/CCM.0b013e31828e9b03
info:pii/0000324620130900000001
info:scp/84883615933
info:pmid/23979365